Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis

BACKGROUND AND AIMS: Cumulative safety and tolerability of budesonide MMX, a once-daily oral corticosteroid for inducing mild to moderate ulcerative colitis remission, was examined. METHODS: Data from three randomized, double-blind, placebo-controlled, phase II or III studies [budesonide MMX 9mg, 6m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Crohns Colitis
Principais autores: Lichtenstein, Gary R., Travis, Simon, Danese, Silvio, D’Haens, Geert, Moro, Luigi, Jones, Richard, Huang, Michael, Ballard, E. David, Bagin, Robert, Hardiman, Yun, Collazo, Raul, Sandborn, William J.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4736820/
https://ncbi.nlm.nih.gov/pubmed/26094251
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ecco-jcc/jjv101
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados